News

ICV Partners Expands Portfolio with Asbestos Abatement Leader

ICV Partners Expands Portfolio with Asbestos Abatement Leader

ICV Partners Strengthens Its Position in Home Services Market

ICV Partners, LLC, a renowned investment firm focused on the lower middle market, has made a notable acquisition by purchasing a significant interest in Environmental Remedies, LLC (ERI), a prominent name in the asbestos abatement industry. This strategic move is set to bolster ERI's service capabilities and geographic reach within the home services market.

Environmental Remedies: A Trusted Leader

Since its inception in 2004, ERI has established itself as a leader in providing comprehensive asbestos abatement services tailored for remediation companies, insurers, and homeowners. The company has carved out its niche by responding to the continuous need for services prompted by fire and water damage, positioning itself as a dependable partner in these critical situations.

Partnership Vision with ICV Partners

In a recent statement, Scott Tamayo, CEO of ERI, expressed enthusiasm about the partnership with ICV. He remarked, “ICV is a great fit for the vision we have for ERI. Their expertise will help us expand our infrastructure and enhance our operational capabilities.” This collaboration is particularly advantageous given ICV's proven track record of successfully aiding family-owned businesses in scaling their operations.

Investment in Essential Services

Jermaine Warren, Managing Director at ICV Partners, highlighted the strategic nature of this investment. He stated, “Our decision to invest in ERI followed meticulous research and evaluation of various opportunities. ERI's market focus aligns perfectly with our strategy of supporting essential service providers whose offerings are crucial.” This reflects ICV's commitment to building a portfolio of companies that demonstrate resilience and consistent demand.

Plans for Growth and Expansion

Under ICV's guidance, ERI aims to enhance its operational framework, invest in team development, and broaden its market footprint. The company is poised to grow through geographic expansion and potential acquisitions, leveraging ICV’s resources and industry expertise. As ERI embarks on this journey, stakeholders can expect innovation and a strengthened market position.

Advisory and Financing Details

The acquisition saw collaborative efforts among financial advisors and legal teams from both sides. Baird served as the financial advisor for ICV, while Intrepid Investment Bankers represented ERI, ensuring a smooth transaction process. Legal representation included Akin Gump Strauss Hauer & Feld LLP for ICV and Greenberg Glusker LLP for ERI. Funding for the acquisition was facilitated by Stellus Capital Management, underscoring the confidence in ERI’s future potential.

About ICV Partners

ICV Partners has been a significant player in private equity since 1999. The firm focuses on transforming lower middle market companies, aiming for sustainable performance improvements across diverse sectors. With an experienced senior investment team, ICV emphasizes control investments in businesses generating between $25 million to $250 million in revenue. Celebrating its 25th anniversary, ICV Partners continues to solidify its reputation as a catalyst for growth in its portfolio companies.

About Environmental Remedies, LLC

Environmental Remedies, LLC operates as a premier asbestos abatement service provider in California. The company is committed to delivering safe and high-quality solutions to its clients, including homeowners and restoration companies. ERI prioritizes compliance and quality, establishing itself as a trustworthy partner in the industry.

Frequently Asked Questions

What prompted ICV Partners to acquire ERI?

The acquisition aligns with ICV's strategy to invest in essential service providers that meet non-discretionary demand.

What services does Environmental Remedies provide?

ERI specializes in asbestos abatement services for remediation firms, insurers, and individual homeowners.

How will the partnership influence ERI's growth?

The partnership aims to enhance ERI's operational capabilities and market presence through geographic expansion and acquisitions.

Who advised both parties in the acquisition process?

Baird and Intrepid Investment Bankers advised ICV and ERI, respectively, with legal assistance from prominent firms for both companies.

What is ICV Partners' investment focus?

ICV seeks to invest in lower middle market firms with revenue between $25 million and $250 million, emphasizing transformational growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Hargreave Hale AIM VCT PLC: New Share Allotment Explained

Updated Category News Views 114

Understanding the Latest Allotment of Shares for Hargreave Hale AIM VCT PLC Recently, Hargreave Hale AIM VCT PLC, known for its investment strategy focusing on AIM-listed companies, announced exciting developments regarding its share allotment. A prospectus was published for the offer of subscription for ordinary shares, aiming to raise up to £20 million. This initiative...

Continue Reading
Minovia Therapeutics Secures FDA Fast Track for MNV-201 Use

Updated Category News Views 203

Minovia's Remarkable Achievement in Myelodysplastic Syndrome Minovia Therapeutics Ltd. has made significant strides in the realm of biotechnology by receiving Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its investigational compound, MNV-201. This designation is pivotal as MNV-201 aims to treat Myelodysplastic Syndrome (MDS), a serious and...

Continue Reading
Transforming Cybersecurity Training into Measurable Investment

Updated Category News Views 160

The Importance of Cybersecurity Training With the rise of cyber threats, it's essential for organizations to understand why investing in cybersecurity training is crucial. Companies like INE Security offer vital insights into how to effectively assess the return on investment (ROI) for these training initiatives. Cybersecurity training isn't merely a means of protection;...

Continue Reading
Inspirato Set to Reveal Q3 2024 Financial Results Soon

Updated Category News Views 79

Upcoming Q3 2024 Results Announcement Inspirato Incorporated (NASDAQ: ISPO), recognized as a premier luxury vacation club, has scheduled its release of financial and operating results for the third quarter of 2024. This announcement is anticipated to take place after market closure on Monday. As an entity that redefines luxury travel experiences, this news is particularly...

Continue Reading
Piedmont Lithium Reports Impressive Q4’24 Operational Results

Updated Category News Views 83

Piedmont Lithium's Stellar Q4 2024 Performance Piedmont Lithium Inc. (NASDAQ: PLL) has announced impressive operational results for the fourth quarter of 2024, marking a crucial step in the company's commitment to the North American lithium supply chain. The company successfully shipped approximately 55,700 dry metric tons (dmt) of spodumene concentrate during this...

Continue Reading